Kuret, T., Peskar, D., Kreft, M
Third, real-world weight loss can be lower than trial averages because of imperfect adherence, side effects, life events and the gap between trial conditions and daily life
Mol Catal 479:110607110627
The announcement was widely interpreted as a signal that the FDA under the new administration would take a more permissive stance toward peptide compounding than the 2023 Pharmacy Compounding Advisory Committee position, which had placed BPC-157 firmly in Category 2 (substances the FDA had concerns about for compounding use)
Even worse, these covert practices contribute to the closure of independent and rural pharmacies, breaking ties to trusted community care and reducing access for patients who depend on in-person support.
This 10mg vial provides research-grade BPC-157 Acetate at 99% purity, HPLC and MS/MS verified per batch